TerminatedNCT04004884
Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA)
Studying Muscular tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Principal Investigator
- Josep EstadellaFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- Intervention
- Ulipristal Acetate(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18-55 years · FEMALE
- Timeline
- 2019 – 2019
Study locations (1)
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04004884 on ClinicalTrials.govOther trials for Muscular tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07352761Bilateral Uterine Artery Occlusion During Laparoscopic MyomectomyAlexandria University
- RECRUITINGNANCT05683041Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic MyomectomyUniversity Hospital, Ghent
- ACTIVE NOT RECRUITINGNCT05607602Are Uterine Fibroids Pro-thrombotic?King's College Hospital NHS Trust